Acrivon Therapeutics | S-3:特定交易注册声明
04/17 16:41 (美东)
Acrivon Therapeutics | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
04/15 16:20 (美东)
Acrivon Therapeutics | 4:持股变动声明-股东 PERCEPTIVE ADVISORS LLC
04/15 08:58 (美东)
Acrivon Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(17.4%),Joseph Edelman(17.4%)等
04/15 08:23 (美东)
Acrivon Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(27.1%),Peter Kolchinsky(27.1%)等
04/11 16:22 (美东)
Acrivon Therapeutics | 8-K:重大事件
04/09 07:09 (美东)
Acrivon Therapeutics | S-8:员工福利计划证券登记
03/29 09:07 (美东)
Acrivon Therapeutics | 8-K:Acrivon Therapeutics公布2023年第四季度和全年财务业绩和业务亮点
03/28 08:04 (美东)
Acrivon Therapeutics | 10-K:年度报表
03/28 07:39 (美东)
Acrivon Therapeutics | 4:持股变动声明-董事 Palani Santhosh
03/06 16:36 (美东)
Acrivon Therapeutics | 3:首次持股声明-董事 Palani Santhosh
03/06 16:31 (美东)
Acrivon Therapeutics | 8-K:重大事件
03/04 08:20 (美东)
Acrivon Therapeutics | 4:持股变动声明-高管 Masson Kristina
02/16 17:19 (美东)
Acrivon Therapeutics | 4:持股变动声明-高管 Miller Mary
02/16 17:18 (美东)
Acrivon Therapeutics | 4:持股变动声明-高管 Holm-Jorgensen Rasmus
02/16 17:17 (美东)
Acrivon Therapeutics | 4:持股变动声明-高管 Devroe Eric
02/16 17:13 (美东)
Acrivon Therapeutics | 4:持股变动声明-高管 Gamelin Erick
02/16 17:13 (美东)
Acrivon Therapeutics | 4:持股变动声明-高管 Blume-Jensen Peter
02/16 17:08 (美东)
Acrivon Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(13.6%),Joseph Edelman(13.6%)等
02/14 17:37 (美东)
Acrivon Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Citadel Advisors LLC(7.4%),Citadel Advisors Holdings LP(7.4%)等
02/14 17:02 (美东)
暂无数据
暂无数据